ConductScience.org, home

Paper11668491

Estimating the world cancer burden: Globocan 2000.

Parkin DM and 3 others. Int J Cancer, 2001. Cited by 2,864 papers, by iCite.

Cite this record

ConductScience Library. Estimating the world cancer burden: Globocan 2000. Papers, record 11668491. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/11668491

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Estimating the world cancer burden: Globocan 2000.
PubMed
Journal
Int J Cancer
PubMed
Year
2001
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
2,864
iCite
Relative citation ratio, by iCite
73.2
iCite
Revised in PubMed
2024-01-09
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Parkin DMD M
2Bray FF
3Ferlay JJ
4Pisani PP

Source PubMed

Download CSV of authors

Topics7

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
NeoplasmsMajor topic
Female
Humans
Incidence
Male
Prevalence
Time Factors

Source PubMed

Download CSV of topics

Trials10

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's recordSource
NCT00462995Surgery for Early Lung Cancer With Preoperative Erlotinib (Tarceva): A Clinical Phase II Trial (SELECT)BackgroundClinicalTrials.gov
NCT01130571Establishment and Characterization of Patient-Derived Non-Small Cell Lung Cancer Xenografts and Cell CulturesBackgroundClinicalTrials.gov
NCT01306058Sorafenib and TRC105 in Hepatocellular CancerBackgroundClinicalTrials.gov
NCT01358097Role of Immune Activation in Response of Head and Neck Squamous Cell Carcinoma to TherapyBackgroundClinicalTrials.gov
NCT01375569TRC105 for Liver Cancer That Has Not Responded to SorafenibBackgroundClinicalTrials.gov
NCT01663792Dietary Seaweed and Early Breast Cancer: A Randomized TrialBackgroundClinicalTrials.gov
NCT01853618Tremelimumab With Chemoembolization or Ablation for Liver CancerBackgroundClinicalTrials.gov
NCT01934829Urea Cream Treatment Sorafenib-Associated HSFR in HCCResultsClinicalTrials.gov
NCT02363218Study on Effectiveness and Safety of Hepatocellular Carcinoma Patients Treated With CyberKnifeBackgroundClinicalTrials.gov
NCT03753932Impact of Fixed Dentures in Head and Neck Cancer (IMFDHAC)ResultsClinicalTrials.gov

Download CSV of trials

Cited by1,129

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2,864 citations.

PMIDTitleJournalYearIn PapersSource
42730755Racial and ethnic survival disparities in primary liver cancer in the United States: a National Cancer Database propensity score-matched study.Hepat Oncol2026https://conductscience.org/library/papers/42730755PubMed
42385012[Disease, social, and economic burden of smoking in Brazil and the impact of tax increases on the economy and on the reduction of morbidity and mortality].Cad Saude Publica2026https://conductscience.org/library/papers/42385012PubMed
42058345Correlation of Ultrasound, Hysteroscopy, and Histology in Postmenopausal Women: A Five-Year Retrospective Observational Study in Dubai.Cureus2026https://conductscience.org/library/papers/42058345PubMed
41746077A Scoping Review of Influences on HPV Vaccine Uptake in the Rural US.Vaccines (Basel)2026https://conductscience.org/library/papers/41746077PubMed
41529252An App-Based Behavioral Support Intervention Promoting Physical Activity (APPROACH) in Patients Diagnosed With Breast, Prostate, or Colorectal Cancer: Protocol for a Randomized Controlled Trial.JMIR Res Protoc2026https://conductscience.org/library/papers/41529252PubMed
41122279Association between perceived social support and post-traumatic growth among female thyroid cancer survivors: the chain mediating role of psychological resilience and coping strategies.Front Psychol2025https://conductscience.org/library/papers/41122279PubMed
41097744Pre-Treatment PET Radiomics for Prediction of Disease-Free Survival in Cervical Cancer.Cancers (Basel)2025https://conductscience.org/library/papers/41097744PubMed
41023473The effects of incretins as a double-edged sword on cancer.Mol Biol Rep2025https://conductscience.org/library/papers/41023473PubMed
40976803The effect of receptor for advanced glycation end products (RAGE) expression on the occurrence, development, and prognosis of gastric cancer.Updates Surg2025https://conductscience.org/library/papers/40976803PubMed
40897496Prevalence of viral hepatitis in sub-Saharan Africa among the general population: an umbrella review of systematic reviews and meta-analyses.BMJ Open2025https://conductscience.org/library/papers/40897496PubMed
40862438Survival time analysis in women with breast cancer using distributional regression models.Cad Saude Publica2025https://conductscience.org/library/papers/40862438PubMed
40739433Factors influencing objective voice profile and speech intelligibility of patients after oral oncological treatment: a prospective cohort study.Support Care Cancer2025https://conductscience.org/library/papers/40739433PubMed
40361349Clinical Applications of the Molecular Landscape of Melanoma: Integration of Research into Diagnostic and Therapeutic Strategies.Cancers (Basel)2025https://conductscience.org/library/papers/40361349PubMed
40223047Materials and effects of intraoral device technologies for complication protection in head and neck cancer radiotherapy: a scoping review.BMC Oral Health2025https://conductscience.org/library/papers/40223047PubMed
39852810Vaccine Hesitancy and Acceptance: The Present and the Future.Vaccines (Basel)2024https://conductscience.org/library/papers/39852810PubMed
39568564Risk factors associated with lymph node metastasis in papillary thyroid cancer: a retrospective analysis based on 2,428 cases.Front Oncol2024https://conductscience.org/library/papers/39568564PubMed
39364468Delay in the Diagnosis of Patients With Head and Neck Cancer: Impact of Different Patient- and Healthcare Provider-Related Factors.Cureus2024https://conductscience.org/library/papers/39364468PubMed
39132050
Tumor diameter and enhancing capsule, as well as previous interventional treatments, as potential predictors of vascular lake phenomenon in hepatocellular carcinoma patients treated with drug-eluting beads transarterial chemoembolization.
J Clin Imaging Sci2024https://conductscience.org/library/papers/39132050PubMed
39006716Outcomes of the Electrothermal Bipolar Vessel Sealing Device and Electrocautery in Modified Radical Mastectomy Patients.Cureus2024https://conductscience.org/library/papers/39006716PubMed
38993193Association Between Time From Surgery to Radiation Therapy and Multimodality Treatment Outcomes in HPV+ Head and Neck Cancer: A Multi-Institutional Cohort Experience.Adv Radiat Oncol2024https://conductscience.org/library/papers/38993193PubMed

See all 1,129 cited byDownload CSV of cited by

Drugs1

The drugs whose trials, in the Pipelines release, list the paper.

DrugChEMBL IDThe trials list it asTrialsIn Drugs and targets
UREACHEMBL985Results1https://conductscience.org/library/drugs/CHEMBL985

Source ChEMBL

Download CSV of drugs

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Comments and corrections
  • References
  • Genes
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/11668491

GET https://conductscience.org/api/papers/v1/11668491/cited_by?page=2